Business Desk: Albert Burla, chairman and CEO of global drug manufacturer Pfizer, said the company is shipping $ 7 million (about Rs 510 crore) of drugs to India from its distribution centers in the US, Europe and Asia. "We are deeply concerned about the situation of Kovid-19 in India, and are heartily with you, your loved ones and all the people of India," he said in a mail sent to Pfizer India employees. He posted this mail on LinkedIn is.
"We are committed to being a partner in India's fight against the disease and are working steadily for the greatest humanitarian relief in the history of our company," said Burla, who is trying to get the drugs to India fast He said that currently Pfizer's partners in distribution centers in the US, Europe and Asia are making efforts to rapidly ship these drugs to India.
"We are donating these medicines to ensure that every needy Kovid-19 patient can get Pfizer medicines in every public hospital in the country," said Burla. These medicines of value will be made available immediately and "we will work together with the government and our NGO partners".
Pfizer-bioetch vaccine to be available in India soon
Albert Burla said that the company is in talks with the Indian government to make its Pfizer-bioetch vaccine available in India soon, so that it can get approval faster. Pfizer had earlier said in April that it had offered to provide its vaccine for a government vaccination program in India at an unprofitable price and was committed to working with the government to make the vaccine available in India.
"Pfizer is aware that the availability of the vaccine is important to end the epidemic," said Burla. Unfortunately our vaccine is not registered in India, although we had applied months ago. "He said," We are currently discussing with the Government of India to expeditiously approve our Pfizer Bioentech vaccine in the country. Have been. ''